Characterisation of peptide interactions that regulate PKCε activation

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Protein Kinase C epsilon (PKCε) activity is regulated by interactions with anchoring proteins like Receptor for Activated C-Kinase 2 (RACK2).
• Peptides derived from the PKCε C2 domain, such as εV1-2 and pseudoεRACK, are known to modulate this interaction and PKCε function.
• The precise mechanisms by which these peptides influence the PKCε-RACK2 complex are not fully understood.

Purpose of the Study:

• To elucidate the binding mechanisms of εV1-2 and pseudoεRACK peptides with PKCε and RACK2.
• To determine if the previously proposed binding interactions of these peptides with PKCε are accurate.
• To identify specific molecular interactions that can be targeted for therapeutic development.

Main Methods:

• Surface Plasmon Resonance (SPR) was employed to detect binding interactions between peptides and RACK2/PKCε.
• Nuclear Magnetic Resonance (NMR) spectroscopy was used to further investigate peptide-protein interactions at an atomic level.

Main Results:

• SPR confirmed that the inhibitory εV1-2 peptide binds to RACK2, effectively inhibiting PKCε binding.
• SPR and NMR analyses revealed that the activating pseudoεRACK peptide and related sequences do not bind to PKCε.
• These findings contradict the previous hypothesis that pseudoεRACK peptides act by directly binding to PKCε.

Conclusions:

• The mechanism of action for the activating pseudoεRACK peptide does not involve direct binding to PKCε.
• The inhibitory εV1-2 peptide's interaction with RACK2 is validated, providing a basis for targeting the PKCε-RACK2 complex.
• These insights are crucial for developing novel therapeutics aimed at modulating PKCε signaling pathways.